Related Experiment Video

Updated: Aug 11, 2026

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
10:43

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration

Published on: May 19, 2016

Molecular roles of MAP kinases and FADD phosphorylation in prostate cancer

K Shimada1, M Nakamura, E Ishida

  • 1Department of Pathology, Nara Medical University School of Medicine, Nara, Japan.

Histology and Histopathology
|January 27, 2006
PubMed

Insights

Mitogen-activated protein (MAP) kinases regulate cell processes and are implicated in prostate cancer. This review explores their roles in cancer development and chemotherapy sensitivity, focusing on apoptosis and cell cycle regulation.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Oncology

Background:

  • Mitogen-activated protein (MAP) kinases are key regulators of cellular processes like gene expression, mitosis, and apoptosis.
  • MAP kinase pathways, including ERK, JNK, and p38, are increasingly recognized for their involvement in human prostate cancer.
  • Evidence suggests these kinases play roles in both the development and chemotherapy response of prostate tumors.

Purpose of the Study:

  • To review the molecular functions of MAP kinases in the context of prostate cancer.
  • To explore the pathological correlations of MAP kinase signaling in prostate neoplastic cells.
  • To highlight novel downstream signaling pathways, particularly involving the Fas-associated death domain protein.

Main Methods:

  • Literature review of existing research on MAP kinases and prostate cancer.
  • Analysis of molecular mechanisms underlying MAP kinase function.
  • Focus on phosphorylation events and their regulatory impact on apoptosis and cell cycle.

Main Results:

  • MAP kinases significantly influence gene expression, cell division, and programmed cell death (apoptosis).
  • Specific MAP kinase pathways (ERK, JNK, p38) are implicated in prostate cancer genesis and chemotherapy resistance.
  • Phosphorylation of the Fas-associated death domain protein by MAP kinases regulates apoptosis and cell cycle in prostate cancer cells.

Conclusions:

  • MAP kinases are critical molecular players in prostate cancer, affecting tumor development and treatment outcomes.
  • Understanding MAP kinase signaling, especially downstream effects on Fas-associated death domain protein, offers insights into novel therapeutic strategies.
  • Targeting MAP kinase pathways may represent a promising approach for managing prostate cancer by modulating apoptosis and cell cycle progression.

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...